To view this email as a web page, click here.

In this issue of Dermatology Times, we highlight the FDA’s role in regulating dermatology devices and the quality of dermatology drugs. We also discuss techniques for better laser resurfacing results and offer a breakdown of your choices of energy-based technologies for facial rejuvenation. Explore these and other topics in this month's issue.
 
Dermatology Times cover
Dermatology Times cover
The future of skin resurfacing
Fractional ablative and nonablative lasers cover a wide variety of indications, but the best skin tightening results often require adjunctive treatment modalities and excellent postprocedural care, says Susan Van Dyke, M.D.
 
Medical device regulation
Laura Marquart, M.D., FAAD, reviewed how the FDA approaches, reviews and approves medical devices integral to dermatologic care at the American Academy of Dermatology’s annual meeting in Washington, D.C. Learn how this process can affect patient care in this article.
 
The drug life cycle
To help providers have a greater understanding of the FDA’s efforts to ensure all drugs are of pharmaceutical quality, Michael Kopcha, Ph.D., RPh, presented on the topic during the American Academy of Dermatology’s Annual Meeting in Washington, D.C.
 
Table: Energy-based device facial rejuvenation options
From lasers to light therapy to non-laser-based thermal tightening, learn each devices’ indications, adverse effects and important treatment takeaways in this table.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.